142 related articles for article (PubMed ID: 12932110)
1. Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators.
Uğur Y; Sari O; Uğur O; Korkusuz P; Varoğlu E; Arslan N; Gürcan N; Yildirim M; Sökmensüer C; Aşan E; Aras T
Ann Nucl Med; 2003 Jun; 17(4):281-7. PubMed ID: 12932110
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
[TBL] [Abstract][Full Text] [Related]
3. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of scintimammography with tc-99m MIBI in clinical practice.
Filippi L; Pulcini A; Remediani S; Masci E; Redler A; Scopinaro F; De Vincentis G
Clin Nucl Med; 2006 Dec; 31(12):761-3. PubMed ID: 17117069
[TBL] [Abstract][Full Text] [Related]
5. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of the quantification of (99M)Tc-MIBI uptake in breast neoplasms in the preoperative assessment of tumor aggressiveness].
Mulero F; Nicolás F; Roca V; Castellón MA; Claver MA; de La Cruz P; Abad L; Nuño De La Rosa JA
Rev Esp Med Nucl; 2000 Aug; 19(4):263-9. PubMed ID: 11062096
[TBL] [Abstract][Full Text] [Related]
7. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
8. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
Mulero F; Roca V; Nicolás F; Castellón I; Fuentes T; Abad L; Illana J; Nuño de la Rosa JA
Rev Esp Med Nucl; 2000 Jun; 19(3):192-8. PubMed ID: 11062082
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m MIBI uptake in breast carcinoma and axillary lymph node metastases.
Kao CH; Wang SJ; Yeh SH
Clin Nucl Med; 1994 Oct; 19(10):898-900. PubMed ID: 7805327
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
13. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
14. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
15. Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA.
Papantoniou V; Sotiropoulou M; Stipsaneli E; Louvrou A; Feda H; Christodoulidou J; Pampouras G; Zerva C; Keramopoulos A; Michalas S
Clin Nucl Med; 2000 Jun; 25(6):434-9. PubMed ID: 10836691
[TBL] [Abstract][Full Text] [Related]
16. Invasive ductal carcinoma arising from dense accessory breast visualized with 99mTc-MIBI breast-specific γ imaging.
Yoon HJ; Sung SH; Moon BI; Kim BS
Clin Nucl Med; 2014 Aug; 39(8):717-20. PubMed ID: 24445272
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic significance of 99mTc-MDP breast scintigraphy. A comparison with histological and molecular parameters].
Dimonte M; Leo G; Marsigliante S; Manca C
Radiol Med; 1999 Nov; 98(5):352-5. PubMed ID: 10780214
[TBL] [Abstract][Full Text] [Related]
18. [Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer].
Mulero F; Nicolás F; Castellón MI; Claver MA; Abad L; Nuño de la Rosa JA
Rev Esp Med Nucl; 2000 Oct; 19(6):416-22. PubMed ID: 11060271
[TBL] [Abstract][Full Text] [Related]
19. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.
Danielsson R; Sánchez-Crespo A; Pegerfalk A; Grabowska H; Larsson SA; Boné B; Aspelin P
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):662-6. PubMed ID: 12616323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
